The blogs are full of two cent comments regarding Christine Drummond's attempt to send food from New Zealand to starving children in Kenya. The story was highlighted by a reporter who needed to stress that Christine was the owner of a dog food company. Kenyan politicians trumpeted the suggestion that the children were to receive donated dog food as a most grievous and racially insensitive cultural insult.   Newspaper sales went up and the politicians bolstered their self-righteous dignity. But what about the children, are they not still starving? Institutions should be judged on how well they are helping others, not how lucrative or secure they are by spinning a story to meet their own needs.

A similar situation exists with healthcare. Therapies based on simply providing added cellular energy to children in developing countries are effective in alleviating diarrhea, a killer of at least five thousand children a day. The same energy based products can restore health to children with pneumonia and possibly represents mankind's best defense against bird flu. These natural products have been called "enerceuticals," as opposed to pharmaceuticals. Herein is the problem because unlike patented drugs that are designed to address specific diseases, these inexpensive natural products can potentially help correct many illnesses of both the developing and the developed world.   

Regulatory agencies are slow to consider such products lest they bite into profits of the future employers of many of their senior staff. It is time to forego profiting from the misery of others and to begin to seriously address the malnutrition and illnesses befalling those with whom we share this earth. More information on efforts towards this goal is available at www.s3support.com and further inquiries are welcomed at s3support@mail.com

Kind regards,

W. John Martin, M.D., Ph.D.